Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Unlinked
No verified creators
Launched
7mo ago
2026-04-27 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Findly.toolsLaunch

    ConverterTo is a free online tool site for converting files between formats.

    Apr 27 · 7mo agoLaunch page

Third-party reviews & case dossiers

Acquisition breakdowns, engineer reviews & open-source metrics
Findly.tools
2026-04-27Source
What engineers like:
Convert images, documents, audio, video, and more — fast, secure, and easy to use.

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct33%
  • Organic Search27%
  • Referrals12%
  • Display Ads9%
  • Other20%

Countries

  • Brazil92%
  • Hungary8%

Search

Domain authority —Domain registered 2026-01-28

KeywordMonthly volume
file converter117.4K
audio converter46.4K
free convert24.3K
online converter24K
webm to gif20.6K

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-13 · Source page

Pages & changes

Tracked since 2026-11-08

Key pages

Weekly snapshots
converter-to.com/ Snapshot 2026-11-13

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does ConverterTo get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ConverterTo and what platforms does it support?
ConverterTo is catalogued under File Conversion & Compression: Free Online File Converter. Supported platforms: Web.

Related products in this category

Utilities / File Conversion & Compression

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.